Use este identificador para citar ou linkar para este item: http://www.repositorio.cdtn.br:8080/jspui/handle/123456789/1198
Título: Dosimetry assessment during the sipping test in the IPR-R1 TRIGA reactor using MCNPX
Título do periódico: Progress in nuclear energy
Autor(es): Gual, Maritza Rodriguez
Mesquita, Amir Zacarias
Campolina, Daniel A. M.
Rodrigues, Rogério R.
Afiliação: Centro de Desenvolvimento da Tecnologia Nuclear, Belo Horizonte, MG
Centro de Desenvolvimento da Tecnologia Nuclear, Belo Horizonte, MG
Centro de Desenvolvimento da Tecnologia Nuclear, Belo Horizonte, MG
Centro de Desenvolvimento da Tecnologia Nuclear, Belo Horizonte, MG
Data do documento: 2016
Palavras-chave: Gamma radiation;Triga-Brasil reactor;Isodose curves;Sipping
Resumo: A sipping test device recently constructed at Centro de Desenvolvimento da Tecnologia Nuclear e CDTN (Nuclear Technology Development Center - CDTN), Belo Horizonte, Brazil, will be used to inspect irradiated fuel elements cladding in the IPR-R1 TRIGA reactor. The device is important to check the integrity of the irradiated fuel elements cladding of this reactor, which can have been affected by corrosion over long periods of time. This paper describes the methodology used in the characterization of gamma doses received by the personnel during the manipulation of the sipping test device. Results are presented for dose rates calculated in the reactor pool surface using the Monte Carlo code MCNPX. Validation of MCNPX calculations of gamma doses were carried out thought comparison with experimental measurements. The difference between the measured and calculated values is lower than 13%. The results provided confirmatory evidence that during the sipping test the manual handling is safety.
Acesso: R
Aparece nas coleções:Artigo de periódico

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Dosimetry assessment during the sipping test in the IPR-R1 TRIGA reactor using MCNPX.pdf2.98 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.